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ABSTRACT: Glucose metabolism in five healthy subjects fasted for 16 h was measured with a combination of
[U-13C]glucose and 2H2O tracers. Phenylbutyric acid was also provided to sample hepatic glutamine for the presence of
13C-isotopomers derived from the incorporation of [U-13C]glucose products into the hepatic Krebs cycle. Glucose
production (GP) was quantified by 13C NMR analysis of the monoacetone derivative of plasma glucose following a
primed infusion of [U-13C]glucose and provided reasonable estimates (1.90 0.19 mg/kg/min with a range of 1.60–
2.15 mg/kg/min). The same derivative yielded measurements of plasma glucose 2H-enrichment from 2H2O by
2H
NMR from which the contribution of glycogenolytic and gluconeogenic fluxes to GP was obtained (0.87 0.14 and
1.03 0.10 mg/kg/min, respectively). Hepatic glutamine 13C-isotopomers representing multiply-enriched oxalo-
acetate and [U-13C]acetyl-CoA were identified as multiplets in the 13C NMR signals of the glutamine moiety of
urinary phenylacetylglutamine, demonstrating entry of the [U-13C]glucose tracer into both oxidative and anaplerotic
pathways of the hepatic Krebs cycle. These isotopomers contributed 0.1–0.2% excess enrichment to carbons 2 and 3 and
0.05% to carbon 4 of glutamine. Copyright # 2003 John Wiley & Sons, Ltd.
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INTRODUCTION
In the postabsorptive state, endogenous glucose produc-
tion (GP) is sustained by a combination of glycogenolysis
and gluconeogenesis. These fluxes can now be measured
in a standard clinical setting by ingestion of 2H2O
1–4
followed by an isotope dilution measurement of glucose
turnover once plasma glucose 2H-enrichment from 2H2O
has reached steady state.1,2,4 Glucose turnover is obtained
by a primed infusion of a non-recyclable glucose tracer
such as [1,6-13C2]glucose,
2 or [6,6-2H2]glucose.
1,4 En-
richment of plasma glucose from both tracers is then
resolved and quantified from a single set of blood
samples obtained at the end of the glucose turnover
measurement. The ratio of 2H-enrichment in positions
5 and 2 of plasma glucose from ingested 2H2O provides a
measure of the fraction of GP derived from gluconeogen-
esis and glycogenolysis.1–4 Meanwhile, the enrichment
level of the infused glucose tracer allows glucose turn-
over and the absolute rate of GP to be estimated.1–4
Absolute gluconeogenic flux is thus estimated as the
product of absolute GP and the fraction of GP derived
from gluconeogenesis, while absolute glycogenolytic
flux is the difference between the absolute rates of GP
and gluconeogenesis.1,2,4 Mass spectrometry (MS) pro-
cedures have been developed for quantifying and resol-
ving plasma glucose enrichment from a mixture of 2H2O
and [6,6-2H2]glucose.
1,4 While this approach is highly
sensitive and utilizes a relatively inexpensive tracer of
glucose turnover, the derivatization procedure is labor-
ious and difficult to routinely implement in a clinical
laboratory setting.1,3–5 Alternatively, 2H NMR analysis of
a monoacetone glucose derivative (MAG) of plasma
glucose6,7 is less sensitive but much simpler to perform
and provides 2H enrichment information for all positions
of glucose. Note that 2H NMR cannot resolve deuterium
isotopomers of glucose, thereby precluding measurement
of GP with [6,6-2H2]glucose in the presence of glucose
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enrichment from 2H2O.* However,
2H enrichment and
13C isotopomers can be resolved by NMR, allowing GP
to be quantified with an alternative 13C-tracer such as
[1,6-13C2]glucose.
2 This approach would be considerably
simplified if all 2H enrichment and 13C isotopomer
information could be obtained from a single MAG
derivative. This cannot be accomplished with
[1,6-13C2]glucose because spin–spin coupling between
carbons 1 and 6 of glucose is abolished following its
conversion to MAG. However, MAG features 13C–13C
couplings that are favorable for resolving and quantifying
a number of other glucose 13C-isotopomers including
[U-13C]glucose, a widely used 13C tracer of GP. There-
fore, a principal goal of this study was to administer a
combination of 2H2O and [U-
13C]glucose and quantify
2H-enrichment levels and glucose 13C-isotopomer distri-
butions by sequential 2H and 13C NMR analysis of MAG.
This provides estimates of GP and its component fluxes
from glycogen and gluconeogenesis from a single NMR
sample.
In addition to providing estimates of GP in humans,
[U-13C]glucose is also a potential hepatic Krebs cycle
tracer as a consequence of carbon recycling (glucose!
pyruvate! glucose) via the Cori and glucose-alanine
cycles. Resolution and quantification of glucose triose
13C-isotopomers formed by recycling has been used to
estimate the fractional contribution of gluconeogenesis to
GP.8 However, this measurement is fraught with both
physiological and methodological uncertainties9–13 and
in any event is made redundant by the metabolic infor-
mation derived from 2H2O. Nevertheless, the presence of
glucose triose isotopomers is proof that the 13C label
must have entered the hepatic Krebs cycle. This is
because [U-13C]glucose is converted to [U-13C]pyruvate
by glycolysis in peripheral tissues and the [U-13C]pyr-
uvate moiety is then exported to the liver as lactate or
alanine. Here, its principal fate is conversion to oxaloa-
cetate (OAA) via pyruvate carboxylase. This results in
the passage of uniformly labeled pyruvate moieties
*There is no significant spin–spin coupling between adjacent deuter-
ium nuclei in either the glucose or monoacetone glucose molecule
hence [6,6-2H2]glucose cannot be resolved from a mixture of [6R-
2H]
and [6S-2H]glucose by 2H NMR.
Figure1. Fate of the 13C of infused [U-13C]glucose. Glycolysis in peripheral
tissues generates [U-13C]pyruvate and its equivalents. These are transported
to liver and enter the hepatic Krebs cycle, principally as anaplerotic carbons
via pyruvate carboxylase. Following carboxylation of [U-13C]pyruvate, the
initial [2,3,4-13C3]OAA product undergoes rapid exchange with malate and
fumarate, resulting in 50% conversion to [1,2,3-13C3]OAA. Both isotopo-
mers can be converted to [2,3-13C2]OAA as a result of the de-carboxylation
and re-carboxylation reactions of pyruvate recycling (dotted arrows) coupled
with OAA$MAL$ FUM exchange.19 Gluconeogenic outflow generates
[U-13C] and [2,3-13C2]PEP and the corresponding [1,2,3-
13C3]- and
[1,2-13C2]glucose isotopomers. These account for the majority (85%) of
glucose 13C-enrichment derived from gluconeogenesis of [U-13C]pyru-
vate.29,30 The corresponding -ketoglutarate isotopomers generated from
condensation of the OAA isotopomers with unlabeled acetyl-CoA are also
shown
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through the hepatic Krebs cycle and gluconeogenic path-
ways, giving rise to a mixture of phosphoenolpyruvate
(PEP) isotopomers which propagate into both triose
moieties of plasma glucose (see Fig. 1). The 13C-iso-
topomer distributions of OAA and other Krebs cycle
intermediates are also preserved in the carbon skeletons
of aspartate, glutamate and glutamine. This was demon-
strated in pigs infused with [U-13C]glucose,14 but to our
knowledge it has not been established in humans. Human
hepatic glutamine can be safely assayed by ingestion of
phenylacetic or phenylbutyric acid, and the 13C isotopo-
mer distribution of the glutamine moiety characterized by
13C NMR of urinary phenylacetylglutamine (PAGN).2,15
Hepatic glutamine 13C isotopomer analysis provides a
comprehensive assessment of Krebs cycle fluxes that can
be integrated with measurements of GP and gluconeo-
genesis.2 To determine if hepatic glutamine 13C-isotopo-
mer information could be obtained in this manner from
[U-13C]glucose, we supplemented the tracers with oral
phenylbutyrate and analyzed urinary PAGN by 13C NMR.
MATERIALS AND METHODS
Human studies
All subjects were studied with a protocol approved by the
University of Coimbra Hospital Ethics Committee and all
gave informed consent prior to admission into the study.
The group consisted of five healthy subjects, three males
and two females with a mean age of 25 7 years (range
19–39 years) and mean weight of 68 10 kg (range 54–
78 kg).
Subjects began fasting at 20:00. During the fast, they
ingested a quantity of sterile and pyrogen-free 70% 2H2O
to attain body water enrichment of 0.5%. For each
subject, the amount of 70%-enriched 2H2O required to
achieve 0.5% body water enrichment was 260 ml. To
reduce the possibility of vertigo, this was divided into two
portions of 130 ml, each taken at 01:00 and 06:00
(5 and 10 h into the fast). For the remainder of the study,
all subjects ingested 0.5% 2H2O ad libitum. At 08:00 the
next day, a 4 h primed infusion of sterile and pyrogenfree
[U-13C]glucose (4.7 mg/kg prime, 0.060 mg/kg/min)
into a peripheral forearm vein was initiated. Subjects
ingested 250–500 mg phenylbutyric acid packaged in
gelatin capsules at 09:40, 10:00 and 10:20, for a total
of 0.75–1.5 g. At 11:00, 11:20, 11:40 and 12:00, 20 ml of
blood were drawn from a contralateral vein. Urine was
collected from 10:30 to 12:00 after which the study was
concluded.
Sampling processing
Blood was stored at 4C and centrifuged within 2 h of
being drawn. For some samples, the plasma supernatant
protein was precipitated by centrifugation following
addition of one-tenth the plasma volume of 70% per-
chloric acid. The supernatant was neutralized with KOH
and lyophilized following centrifugation of precipitated
KClO4. For the remaining samples, plasma protein was
precipitated by the addition of 4 vols methanol per
volume of plasma and the supernatant was recovered by
filtration via a Buchner funnel. The methanol was re-
moved by rotary evaporation at 40C after which the
remaining aqueous fraction was removed by lyophiliza-
tion. For conversion of plasma glucose to the monoace-
tone derivative, the lyophilized extracts were treated with
3–20 ml anhydrous acetone enriched to 0.15% with
acetone-d6 to which concentrated sulfuric acid (4% v/v)
was added. The solution was quickly cooled to room
temperature, and MAG was prepared for NMR analysis
as described.16
Urine samples were adjusted to pH 7.0 and incubated
overnight with 10000 U of urease per sample. A trace of
sodium azide was also added to inhibit possible infection
from airborne microorganisms. The samples were then
depleted of protein by addition of perchloric acid, fol-
lowed by neutralization, centrifugation and lyophiliza-
tion. Upon reconstitution in 2–3 ml water, the pH was
adjusted to 8.0, the sample loaded on to a 5 ml Dowex-
1 8-acetate column and washed with 25 ml of water.
PAGN was eluted with 15 ml of 10 M acetic acid. This
fraction was evaporated and re-suspended in 0.5–1.0 ml
water. The pH was adjusted to 7.0 with NaOH, and the
samples were centrifuged in Eppendorf tubes. A 0.5 ml
aliquot of the supernatant was introduced into a 5 mm
NMR tube and 100ml of CD3CN were added to provide a
deuterium signal for lock and shimming.
NMR spectroscopy
2H NMR spectra of urine water and MAG were acquired
at 11.75 T with a Varian Unity 500 system equipped with
a 5 mm broadband ‘switchable’ probe with z-gradient
(Varian, Palo Alto, CA, USA) as described.17 Absolute
enrichment of glucose hydrogen 2 in selected MAG
samples was obtained by addition of a 2H-formate stan-
dard of known enrichment to the NMR sample.16 13C
NMR spectra of MAG were obtained following addition
of 100 ml CD3CN to provide a lock signal.
13C NMR
spectra of PAGN were obtained following addition of
100ml CD3CN to a neutral, aqueous solution of PAGN in
1.0 ml distilled water and incorporation of 0.6 ml of
this mixture into a 5 mm NMR tube. In all cases, partially
saturated 13C NMR spectra were obtained with an acqui-
sition time of 2 s and a pulse delay of 1 s. The number of
acquisitions ranged from 5000 to 25000. For some
samples, and for MAG prepared from [U-13C]glucose
of the infusion solution, quantification of carbon 1
enrichment was performed by 1H NMR. This was
achieved by pre-saturation of the acetonitrile signal and
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applying selective 13C-decoupling in the 65–85 ppm
spectral window. The decoupling procedure improves
the resolution of the 13C-satellite signals by removing
long-range 13C–1H couplings between hydrogen 1 and
carbons 2–6 while retaining the direct coupling between
13C and 1H in position 1.17 For all plasma glucose
samples, MAG carbon 1 13C-enrichment was quantified
from its 13C NMR spectrum using the approach of
Brainard et al.18 Here, the intensity of the 13C singlet
component of any given glucose resonance is assumed to
represent the natural abundance 13C-enrichment of
1.11%. The intensity of a 13C–13C spin-coupled multiplet
signal is expressed as fractional 13C enrichment by
obtaining the ratio of the multiplet and singlet signal
and multiplying by 1.11%. For example, if a glucose 13C
resonance features a multiplet whose intensity is twice
that of the singlet, then the percentage 13C-enrichment
represented by the glucose 13C-isotopomers that contri-
bute to that multiplet signal will be 2 1.11¼ 2.22%.
Deuterium enrichment of body water was determined by
2H NMR analysis of plasma and urine 2H water enrich-
ment as previously described.16
Sterile and pyrogen-free [U-13C]glucose was obtained
from Cambridge Isotopes (Cambridge, MA, USA). Sterile
and pyrogen-free 70% 2H2O was obtained from
Cambridge Isotopes and Eurisotop, Gif-sur-Yvette,
France. All NMR spectra were analyzed using the
curve-fitting routine supplied with the NUTS PC-based
NMR spectral analysis program (Acorn NMR Inc.,
Fremont, CA, USA).
Calculations
Total 13C-enrichment of plasma glucose carbon 1 and
enrichment of the [U-13C]glucose isotopomer were de-
termined from the carbon 1 multiplet of MAG. The
singlet fraction (S) is assumed to be derived from natural
abundance 13C and is assigned an enrichment value of
1.11%.18 The Q125 signal is assumed to reflect contribu-
tion from [U-13C]glucose. Therefore, the enrichment of
level of plasma [U-13C]glucose (Ep) is simply related to
the ratio of the Q125 and S signals.
Plasma glucose enrichment (%)¼ 1=S 1.11
Plasma[U-13C]glucose enrichment,
Epð%Þ ¼ Q125=S 1:11
GP was calculated as follows:
GP ¼ ½i ðEi=EpÞ  i
where i¼ infusion rate of [U-13C]glucose, and Ei and
Ep¼ percentage enrichment of infusate and plasma
[U-13C]glucose, respectively.
Relative rates of glycogenolysis and gluconeogenesis
from glycerol and the Krebs cycle were estimated from
2H-enrichment of hydrogens 2, 5 and 6S of glucose (H2,
H5 and H6S) as determined by 2H NMR analysis of
MAG.2,16 These relative rates were converted to absolute
values by multiplication with GP:
Total gluconeogenesis¼H5=H2GP
Gluconeogenesis from glycerol¼ [(H5-H6S)=H2]GP
Gluconeogenesis from Krebs cycle¼H6S=H2GP
Glycogenolysis¼ (1—H5=H2)GP.
RESULTS AND DISCUSSION
Analysis of glucose isotopomers by 13C NMR
of MAG
13C NMR spectroscopy of MAG in acetonitrile yields
significant advantages for analysis of glucose 13C-
isotopomers compared with conventional 13C NMR spec-
troscopy of glucose in aqueous solution. As MAG, each
hexose carbon is represented by a single well-resolved
resonance and narrow 13C linewidths of 0.5–0.8 Hz are
routinely obtained. The low salt content allows effective
and reproducible implementation of observe and decou-
pling pulses. MAG carbons exhibit 13C–13C coupling
with nearest neighbors and also with more distant carbons
(see Table 1), providing the basis for resolving a diversity
of glucose 13C-isotopomers by 13C NMR. For MAG
synthesized from [U-13C]glucose, all 13C–13C couplings
of the hexose moiety contribute to the observed NMR
multiplets. Carbon 1 is the optimum resonance for
quantification of the [U-13C]glucose isotopomer since it
features a well-resolved quartet signal as a result of
coupling to carbons 2 and 5 (see Table 1). For MAG
prepared from plasma glucose, it is assumed that this
quartet represents [U-13C]glucose since dilution of the
tracer by endogenous substrates is such that the prob-
ability of generating glucose molecules enriched in posi-
tions 1, 2 and 5 via recycling or from other pathways is
negligible. The anticipated glucose triose isotopomers
generated by recycling (see Fig. 1) generate a doublet
signal which is resolved from the quartet assigned to
[U-13C]glucose. The contribution of singly-labeled car-
bon 1 from either [U-13C]glucose, or its recycled pro-
ducts,* is assumed to be insignificant. Finally, analysis of
13C–13C spin-coupled multiplets in resonances 2–6 of
MAG (some of which are discernable in Fig. 2) can
potentially further resolve and quantify the distribution of
glucose triose 13C-isotopomers. However, under our
study conditions, the signal-to-noise ratios of these multi-
plets were generally too low for reliable quantification.
*Estimated to be 10% of the D12 signal19 and therefore 1% of the
natural abundance signal.
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Estimation of plasma [U-13C]glucose
enrichment and GP by 13C NMR
Figure 2 shows a 13C NMR spectrum derived from the
MAG derivative of plasma glucose following infusion of
[U-13C]glucose. The very low 2H-enrichment levels of
the methine and methylene hydrogens of plasma glucose
(0.2–0.5%) as a consequence of the ingested 2H2O did
not generate detectable levels of either 2H-isotope-shifted
or 2H—13C-coupled signals in MAG.2 Contributions
from [U-13C]glucose, represented by the Q125 quartet,
were well resolved and accounted for the majority of the
carbon 1 resonance. For each subject, the coefficient of
variation for the estimates of [U-13C]glucose enrichment
obtained from sequential blood samples averaged 5%
(range 1–11%) indicating steady-state levels of
[U-13C]glucose. Contributions from glucose recycling,
represented by the D12 doublet, accounted for only
5–10% of the carbon 1 resonance (see Table 2). The
relatively low abundance of recycled 13C is consistent
with extensive dilution at several points in the Cori cycle9
and by unlabeled hepatic precursors of glucose.13 Esti-
mates of carbon 1 fractional 13C-enrichment and that of
[U-13C]glucose are listed in Table 2. In five selected
samples, carbon 1 fractional 13C-enrichment values ob-
tained by 13C NMR were identical to those obtained by
1H NMR analysis (data not shown). This agreement
supports the validity of the method of Brainard et al.18
for measuring fractional 13C-enrichment directly from
the 13C NMR spectrum under the conditions of our study.
From the 13C NMR data, estimates of GP were
obtained (Table 3), which are in good agreement with
recent NMR and MS measurements.2,8,13 Our estimates
are also concordant with the study of Brainard et al.18
Here, plasma glucose was analyzed directly following
[U-13C]glucose infusion in a single overnight-fasted
healthy subject and the contribution of recycled 13C
was not resolved from that of the infused [U-13C]glucose.
The agreement between our data and that of Brainard
et al. is not surprising given the relatively low levels of
recycled 13C isotopomers compared with those of
[U-13C]glucose. If the contribution of recycled 13C is
added to that of [U-13C]glucose, it results in a 9–15%
inflation of [U-13C]glucose enrichment, and a corre-
sponding 9–15% underestimation of GP. However, this
error will be compounded if glucose recycling is high, or
if there is less dilution of 13C from endogenous unlabeled
substrates. Glucose recycling, as measured with [U-13C]
glucose, has been shown to be significantly increased in
patients with cancer and type-2 diabetes.20–22
Table 1. 13C and 1HNMR chemical shifts and 13C–1H coupling constants for the hexose and acetone (A1, A2)
moieties of monoacetone glucose under the conditions of the experiment (50 C, 90% acetonitrile/10% H2O
solvent). The quaternary carbon signal of the acetone group is not included and the absolute stereochemistry of
each acetone methyl group is not assigned
1H chemical shifts 13C chemical shifts 13C–1H coupling constants 13C–13C coupling constants
(ppm)a (ppm)b (Hz) (Hz)
1 5.83 1 105.4 JC1—H1 184.7 JC1—C2 33.6 Hz
2 4.44 2 85.5 JC2—H2 159.8 JC2—C3 43.2 Hz
3 4.17 3 74.8 JC3—H3 153.2 JC3—C4 38.0 Hz
4 3.96 4 80.6 JC4—H4 146.1 JC4—C5 46.2 Hz
5 3.83 5 69.7 JC5—H5 143.0 JC5—C6 40.8 Hz
6-proR 3.67 6 64.4 JC6—H6R 145.3 JC1—C5 3.9 Hz
6-proS 3.53 A1 26.5 JC6—H6S 145.2 JC2—C4 1.4 Hz
A1 1.40 A2 25.9 JC2—C5 1.4 Hz
A2 1.25 JC3—C5 1.4 Hz
JC3—C6 1.5 Hz
JC4—C6 1.7 Hz
a Proton shifts relative to the acetonitrile methyl 1H signal at 1.94 ppm.
b Carbon shifts relative to the acetonitrile-d3 cyano
13C signal at 118.7 ppm.
Figure 2. 13C NMR spectrum of MAG. The number above
each signal refers to its position in the original glucose
molecule. The multiplet of carbon 1 is shown in the ex-
panded inset. S¼natural abundance singlet; D12¼doublet
from coupling between carbons 1 and 2; Q125¼quartet
from coupling between carbons 1, 2 and 5. The spectrum
represents the sum of 25000 free-induction decays (17.8 h)
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2H enrichment information from 2H2O and
integration with estimates of GP from
[U-13C]glucose
The 2H2O enrichment data and fractional gluconeogenic
rates from these subjects as measured by 2H NMR
analysis of MAG have been reported in a separate
account.23 A representative 2H NMR spectrum of MAG
demonstrating the typical distribution of 2H signal in-
tensities in the glucose hexose skeleton is shown in Fig. 3.
The relative enrichment of hydrogens 2, 5 and 6S of
glucose are obtained by quantifying the relative areas of
the respective signals in the spectrum.2,16,23 For two of
the subjects, derivatization of glucose to MAG was
incomplete; hence blood samples were pooled to obtain
spectra with acceptable signal-to-noise. For the three
remaining subjects, a set of three deuterium spectra
were obtained. For each of these subjects, the coefficient
of variance associated with the hydrogen 5/hydrogen 2
and hydrogen 6S/hydrogen 2 enrichment ratio measure-
ment was 10%. For the group of five subjects, the
enrichment of glucose hydrogen 2 was estimated to be
98 7% that of body water, indicating that all plasma
glucose molecules had undergone complete exchange of
hydrogen 2 and body water via interconversion of
glucose-6-phosphate and fructose-6-phosphate.1 The re-
lative 2H-enrichments of positions 2, 5 and 6S and the
fractional contribution of glycogen and gluconeogenic
substrates to GP calculated from this data are summar-
ized in Table 4. The data show that at 16 h of fasting,
gluconeogenesis accounts for 50% of GP, with ana-
plerotic outflow from the Krebs cycle contributing the
bulk of gluconeogenic flux with only minor contributions
from glycerol. These values are in good agreement with
recent NMR and MS measurements.1,2 The relative rates
of gluconeogenesis and glycogenolysis were converted to
absolute flux values by multiplication with GP and these
absolute flux values are presented in Table 3.
Under the conditions of this study, estimates of gly-
cerol gluconeogenesis are associated with relatively high
Table 3. 2H enrichment ratios of hydrogen 2,5 and 6S of plasma glucose (H2, H5 and H6S, respectively) derived
from the relative areas of the 2H NMR signals of MAG. The fractional contribution of glycogen, glycerol and Krebs
cycle to GP estimated from the 2H-enrichment ratios is also shown. Enrichment of glucose hydrogen 2 is arbitrarily
set to 1.0
2H enrichment ratios of plasma glucose Fractional contribution of substrates to GP (%)
Subject H2 H5 H6S Glycogen Glycerol Krebs cycle
1a 1.00 0.57 0.56 43 1 56
2 1.00 0.59 0.58 41 1 58
3a 1.00 0.55 0.45 45 10 45
4 1.00 0.51 0.40 49 11 40
5 1.00 0.50 0.36 50 14 36
a Values derived from a single NMR spectrum of two to three pooled MAG samples.
Table 4. Estimates of GP from glycogen, glycerol and the Krebs cycle from the integration of 2H- and [U-13C]glucose
enrichment measurements of plasma glucose
Subject [U-13C]Glucose GP (mg/kg/min) GP from Glycogen Total GNG GP from Glycerol GP from Krebs
infusion rate (mg/kg/min) (mg/kg/min) (mg/kg/min) cycle (mg/kg/min)
(mg/kg/min)
1 0.046 1.60 0.01 0.69 0.91 0.02 0.89
2 0.071 1.80 0.21 0.74 1.06 0.02 1.04
3 0.066 2.15 0.18 0.97 1.18 0.22 0.96
4 0.060 1.93 0.07 0.95 0.98 0.21 0.77
5 0.065 2.00 0.07 1.00 1.00 0.26 0.74
MeanSD 0.062 0.010 1.90 0.19 0.87 0.14 1.03 0.10 0.15 0.12 0.88 0.13
Figure3. 2H NMR spectrum of MAG prepared from a single
plasma glucose blood sample of subject 4. The number
above each signal represents its position in the glucose
skeleton. The spectrum represents 53 850 free-induction
decays for a total collection time of 18 h
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levels of uncertainty (note the range and standard devia-
tion for glycerol gluconeogenesis in Table 3 and 4). This
is partly due to the fact that the fractional contribution of
glycerol to GP is obtained by subtraction of two signals of
comparable intensities (hydrogen 5 and 6S) that are
associated with noise levels of 10%. In addition,
some of the difference in 2H enrichment between hydro-
gens 5 and 6S of glucose may be due to incomplete
exchange of hydrogen between water and gluconeogenic
precursors that pass through the Krebs cycle.2 This results
in an overestimate of glycerol gluconeogenesis and a
corresponding underestimate of gluconeogenesis from
the Krebs cycle. Note that this latter uncertainty cannot
be minimized by improving the signal to noise ratio of the
2H NMR spectrum.
PAGN enrichment and 13C-isotopomer
distributions from [U-13C]glucose
Generally, excess 13C-enrichment levels in the glutamine
carbons of PAGN following [U-13C]glucose administra-
tion were very low, ranging from 0.1 to 0.2% for carbons
2 and 3 and 0.05% for carbon 4. These enrichment
levels were lower than that of the recycled glucose
isotopomers indicating incomplete equivalence of 13C-
enrichment between oxaloacetate (OAA) of the hepatic
Krebs cycle and the OAA moiety of glutamine. This is
probably due to dilution of 13C-glutamine derived from
the hepatic Krebs cycle by the influx of unlabeled
glutamine from peripheral tissues.24–27 Not surprisingly,
the largest multiplet contributions was derived from
subject 2, who received the highest infusion rate of
[U-13C]glucose (0.071 mg/kg/min), and is shown in
Fig. 4. PAGN spectra from the remaining subjects had
somewhat lower multiplet intensities. Generally, while
individual multiplet components had adequate signal-to-
noise ratios (see inset of Fig. 4), they were difficult to
quantify due their small size in comparison to the large
central singlet signal. In particular, they were highly
susceptible to minor shimming maladjustments, includ-
ing artifact signals from spinning sidebands. Further-
more, as a consequence of the very low levels of excess
13C-enrichment from the tracer, the multiplets contain
significant contributions from natural abundance 13C–13C
isotopomers, present at 0.011%. For the carbon 2
resonance, these were estimated to account for 10% of
the D23, and 25% of the D12 signal while for the carbon
4 resonance, they accounted for 14% of the doublet
signal.* Uncorrected, these natural abundance contribu-
tions would substantially distort metabolic flux estimates
derived from the multiplet intensities. Nevertheless, Fig.
4 demonstrates the potential of obtaining PAGN 13C-
isotopomer information from a primed infusion of
*The contribution was estimated by multiplying the relative area of the
central singlet by 0.011 and comparing this value with the relative areas
of the multiplets.
Figure 4. 13C NMR spectrum of phenylacetylglutamine from subject 2
featuring the resonances of carbons 2, 3 and 4 of the glutamine moiety
(labeled 2, 3 and 4). The multiplet of carbon 2 is shown in expanded form
and the components labeled as follows: S¼ singlet component;
D12¼doublet from coupling between carbons 1 and 2; D23¼doublet
doublet from coupling between carbons 2 and 3; Q¼quartet from
coupling between carbons 1,2 and 3; X¼unknown signal that coincides
with one of the quartets. The spectrum represents the sum of 25000
free-induction decays (17.8 h)
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[U-13C]glucose and qualitatively reveals some important
characteristics of hepatic Krebs cycle fluxes. In the
carbon 2 multiplet, the intensity of the D23 signal clearly
exceeds that of the quartet (Q), indicating a substantial
excess of [2,3-13C2]glutamine over [1,2,3-
13C3]gluta-
mine. This is consistent with extensive cycling of carbons
between pyruvate and OAA19 and is in agreement with
the glutamine 13C-isotopomer distribution following me-
tabolism of [U-13C]propionate.19 The presence of a
doublet corresponding to [4,5-13C2]glutamine in the
carbon 4 signal indicates entry of [U-13C]acetyl-CoA
into the cycle, presumably from oxidation of [U-13C]pyr-
uvate via pyruvate dehydrogenase.
The multiplet information from carbons 2, 3 and 4 of
PAGN therefore provide the basis for describing hepatic
anaplerotic, oxidative and pyruvate recycling fluxes. This
analysis assumes that the 13C-isotopomer distribution of
PAGN is entirely derived from the hepatic Krebs cycle.
Since the liver also receives glutamine from peripheral
tissues, notably skeletal muscle, the possibility exists
that 13C-enriched glutamine could be produced via per-
ipheral oxidation of [U-13C]glucose, then exported to
the liver and incorporated into PAGN. This would distort
the observed 13C-isotopomer distribution because
anaplerotic and pyruvate recycling activities are much
smaller in muscle compared to liver. In principle, the
extent of such extra-hepatic contributions can be gauged
by comparing the PAGN isotopomer distribution derived
from [U-13C]glucose with that obtained from a more
specific hepatic tracer, such as [U-13C]lactate or
[U-13C]alanine.
Assuming that PAGN excess 13C-enrichment and 13C
NMR multiplet intensities increase linearly with the rate
of [U-13C]glucose infusion, we anticipate that a doubling
of the glucose infusion rates used in this study to 0.12–
0.15 mg/kg/min (3 g of [U-13C]glucose per subject)
would be sufficient to routinely provide good-quality
PAGN isotopomer information by 13C NMR. Meanwhile,
these higher infusion rates would generate plasma
[U-13C]glucose enrichment levels of 5–6%; sufficiently
dilute for estimating GP with the current approach.
Additionally, the application of new indirect detection
methods such as the J-resolved HSQC procedure28 would
eliminate spinning sideband artifacts while substantially
improving the sensitivity of the 13C-isotopomer measure-
ments.
In summary, we developed a highly practical method
for quantifying GP and absolute gluconeogenic and
glycogenolytic fluxes by NMR analysis of a single
convenient derivative of plasma glucose following
administration of [U-13C]glucose and 2H2O. We also
demonstrated the potential for obtaining complementary
hepatic Krebs cycle fluxes by noninvasive analysis of
hepatic glutamine isotopomers from a single additional
urine sample. The approach could be valuable for obtain-
ing a detailed assessment of hepatic glucose and Krebs
cycle metabolism in a standard hospital setting.
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